We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOW
2551
DELISTED
WideOpenWest
WOW
$1.15M ﹤0.01%
154,802
+1,638
+1% +$10.4K
NGVC icon
2552
Vitamin Cottage Natural Grocers
NGVC
$624M
$1.15M ﹤0.01%
116,044
+550
+0.5% +$5.05K
EGIO
2553
DELISTED
Edgio, Inc. Common Stock
EGIO
$1.15M ﹤0.01%
7,016
+222
+3% +$35.1K
SCPL
2554
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$1.14M ﹤0.01%
92,815
+1,642
+2% +$17.4K
LFVN icon
2555
LifeVantage
LFVN
$81.6M
$1.14M ﹤0.01%
72,757
UBX
2556
DELISTED
Unity Biotechnology
UBX
$1.14M ﹤0.01%
15,740
+690
+5% +$48.7K
TCRR
2557
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1.14M ﹤0.01%
79,420
+986
+1% +$15.2K
ELOX
2558
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$1.13M ﹤0.01%
3,823
+45
+1% +$9.07K
HPR
2559
DELISTED
HighPoint Resources Corporation
HPR
$1.13M ﹤0.01%
13,306
+154
+1% +$10K
CRD.A icon
2560
Crawford & Co Class A
CRD.A
$640M
$1.12M ﹤0.01%
97,714
+1,151
+1% +$12.6K
FSTR icon
2561
Foster
FSTR
$404M
$1.11M ﹤0.01%
57,470
+889
+2% +$17.3K
GRTS
2562
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1.11M ﹤0.01%
123,509
+1,257
+1% +$10.5K
GOTU icon
2563
Gaotu Techedu
GOTU
$432M
$1.1M ﹤0.01%
+50,483
New +$858K
AMTB icon
2564
Amerant Bancorp
AMTB
$1.14B
$1.1M ﹤0.01%
50,589
+1,531
+3% +$31.9K
FSB
2565
DELISTED
Franklin Financial Network, Inc.
FSB
$1.1M ﹤0.01%
32,129
+1,048
+3% +$34.5K
AMNB
2566
DELISTED
American National Bankshares Inc
AMNB
$1.09M ﹤0.01%
27,662
+1,105
+4% +$41.1K
LXRX icon
2567
Lexicon Pharmaceuticals
LXRX
$1.07B
$1.09M ﹤0.01%
262,850
+31,439
+14% +$121K
SPNE
2568
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$1.09M ﹤0.01%
90,785
-2,812
-3% -$34.3K
GPX
2569
DELISTED
GP Strategies Corp.
GPX
$1.08M ﹤0.01%
81,455
+2,449
+3% +$30.4K
GBLI icon
2570
Global Indemnity Group
GBLI
$409M
$1.08M ﹤0.01%
36,317
-1,228
-3% -$32.6K
RBBN icon
2571
Ribbon Communications
RBBN
$363M
$1.08M ﹤0.01%
347,290
+8,647
+3% +$34.4K
CURO
2572
DELISTED
CURO Group Holdings Corp.
CURO
$1.08M ﹤0.01%
88,398
-6,362
-7% -$85.1K
LXFR icon
2573
Luxfer Holdings
LXFR
$457M
$1.08M ﹤0.01%
58,118
+3,377
+6% +$58.1K
ACRE
2574
Ares Commercial Real Estate
ACRE
$261M
$1.07M ﹤0.01%
67,714
+871
+1% +$13.5K
SRNE
2575
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.07M ﹤0.01%
317,029
+23,894
+8% +$57K

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.